News About: Pharm. Industry


Would it be possible for small pharmas to conduct co-R&D?

Chairman Yong-Joon Jo(CEO/President of Dongkoo Bio&Pharma) at the Korea Pharmaceutical Ind. Coop., which currently has approximately 100 medium and small pharmaceutical companies as its member, said at an interview wi...

Hanmi Pharm acquires approval of hypertension/hyperlipidemia treatment

Hanmi Pharm(CEO Jong-Soo Woo, Sae-Chang Kwon) announced on the 17th that ‘Amosartan Q,’ a 3-substance combination drug with 2 antihypertensive substances and 1 anti-hyperlipidem...

Novartis, “We made payments, but never understood what RTM for”

While people are paying interests in whether Novartis shared information internally, it was hard to check clear facts even at examination of a witness from its anticancer depart...

Dong-A Pharm Bacchus’s manufacturing performance of KRW 223.7 billion

‘Bacchus,’ a Dong-A Pharm’s energy drink, was known to record a manufacturing performance of KRW 232.7 billion last year. According to the quasi drug manufacturing performance ...

Hanmi Pharm far ahead of other pharmas in medicine manufacturing

It was observed Hanmi Pharm has been far ahead of others in the 1st position in medicine manufacturing performance since 2014. According to the current state of medicine manufa...

Dong-A Socio Holdings first adopts blind recruiting method in pharma industry

In order to spread the fair recruiting culture focusing on abilities without any prejudice, Dong-A Socio Group will lead the way. Dong-A Socio Holdings(CEO/President Jong-Hyun ...

Soom-to-be-expired medicines are also distributed due to manufacturing suspension

It was observed pharmaceutical products soon to be expired have been distributed to the market as pharmaceutical companies have continuously caused temporary out-of-stock and manufacturing suspension. Thus, returning ...

Jeil Pharmaceutical acquires European EDQM approval for ‘cephalosporin’ ingredient

Jeil Pharmaceutical(CEO/President Suk-Jae Sung) announced ‘cefpodoxime’ manufactured at the Baekam Factory’s ‘cephalosporin’ manufacturing facility located in Cheoin-gu, Yongin-...

SFT strongly denounce pharmaceutical companies’ illegal rebates

The Society for the Future of Pharmacists(SFP) pointed out Dong-A Pharm’s illegal rebates, announcing a statement of denunciation about rebate activities of pharmaceutical companies. Dong-A Pharm was prosecuted for p...

GSK carries out promotions of personnel to director-level positions in medicine and consumer health business

In order to have continuous growth and accelerate R&D innovation in the medicine, vaccine and consumer healthcare businesses, GSK promoted personnel in a director-level position. The Korean branch of GSK, which leads...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.